# Clinical Trial of Apomorphine Subcutaneous Infusion in Patients With Advanced Parkinson's Disease

> **NCT02006121** · PHASE3 · COMPLETED · sponsor: **Britannia Pharmaceuticals Ltd.** · enrollment: 107 (actual)

## Conditions studied

- Parkinson's Disease

## Interventions

- **DRUG:** Apomorphine hydrochloride
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02006121
- **Lead sponsor:** Britannia Pharmaceuticals Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-03-03
- **Primary completion:** 2016-06-06
- **Final completion:** 2017-06-08
- **Target enrollment:** 107 (ACTUAL)
- **Last updated:** 2019-07-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02006121

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02006121, "Clinical Trial of Apomorphine Subcutaneous Infusion in Patients With Advanced Parkinson's Disease". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT02006121. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*